We found that SMSr/PE-PLC deficiency attenuated high-fat diet/fructose–induced fatty liver and NASH, and attenuated glucosylceramide accumulation–induced NASH, fibrosis, and tumor formation. The gene discussed is HSPG2; the disease is metabolic dysfunction-associated steatohepatitis.